“Risk Management” May Be Too Risky For Pharmacy, NACDS Tells FDA
Executive Summary
The participation of retail pharmacy in FDA-approved risk management programs may depend on "risk management" of a different kind: whether retailers feel sufficiently shielded from any added liability under novel regulatory schemes
You may also be interested in...
FDA Labeling Reform Will Trim Adverse Event Section, Temple Says
FDA's package insert reform initiatives include a thinning out of the adverse event section, CDER Office of Medical Policy Director Robert Temple, MD, told a public workshop on risk management April 10
Pharmacists Risk Management Survey: PhRMA, APhA Differ On Targets
FDA's proposed survey on pharmacists' knowledge of drug risk management programs should be targeted to community pharmacists, the Pharmaceutical Research & Manufacturers of America said
FDA Labeling Reform Will Trim Adverse Event Section, Temple Says
FDA's package insert reform initiatives include a thinning out of the adverse event section, CDER Office of Medical Policy Director Robert Temple, MD, told a public workshop on risk management April 10